홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

(2S)-6-[[(2S)-3-(1H-indol-3-yl)-2-[(4-nitrophenyl)sulfonylamino]propanoyl]amino]-2-[isobutyl(p-tolylsulfonyl)amino]hexanoic acid → (2S)-6-[[(2S)-2-[(4-aminophenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoyl]amino]-2-[isobutyl(p-tolylsulfonyl)amino]hexanoic acid

HRID 397759
노트
인쇄 미리보기

반응식

HRID 397759 반응식
C(N(S(C1C=CC(C)=CC=1)(=O)=O)[C@H](C(O)=O)CCCCN)C(C)C.[N+](C1C=CC(S(N[C@H](C(O)=O)CC2C3C(=CC=CC=3)NC=2)(=O)=O)=CC=1)([O-])=O.[CH3:52][C:53]1[CH:58]=[CH:57][C:56]([S:59]([N:62]([C@H:67]([C:99]([OH:101])=[O:100])[CH2:68][CH2:69][CH2:70][CH2:71][NH:72][C:73]([C@@H:75]([NH:86][S:87]([C:90]2[CH:95]=[CH:94][C:93]([N+:96]([O-])=O)=[CH:92][CH:91]=2)(=[O:89])=[O:88])[CH2:76][C:77]2[C:85]3[C:80](=[CH:81][CH:82]=[CH:83][CH:84]=3)[NH:79][CH:78]=2)=[O:74])[CH2:63][CH:64]([CH3:66])[CH3:65])(=[O:61])=[O:60])=[CH:55][CH:54]=1>>[CH3:52][C:53]1[CH:54]=[CH:55][C:56]([S:59]([N:62]([C@H:67]([C:99]([OH:101])=[O:100])[CH2:68][CH2:69][CH2:70][CH2:71][NH:72][C:73]([C@@H:75]([NH:86][S:87]([C:90]2[CH:91]=[CH:92][C:93]([NH2:96])=[CH:94][CH:95]=2)(=[O:88])=[O:89])[CH2:76][C:77]2[C:85]3[C:80](=[CH:81][CH:82]=[CH:83][CH:84]=3)[NH:79][CH:78]=2)=[O:74])[CH2:63][CH:64]([CH3:66])[CH3:65])(=[O:60])=[O:61])=[CH:57][CH:58]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 3

HCID 508531(2S)-6-[[(2S)-3-(1H-indol-3-yl)-2-[(4-nitrophenyl)sulfonylamino]propanoyl]amino]-2-[isobutyl(p-tolylsulfonyl)amino]hexanoic acidHCID 1572095Nalpha(4-nitrobenzenesulfonyl)-L-tryptophanHCID 23552860Nalpha-isobutyl-Nalpha-(4-methylbenzenesulfonyl)-L-lysine

생성물 1

HCID 508536(2S)-6-[[(2S)-2-[(4-aminophenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoyl]amino]-2-[isobutyl(p-tolylsulfonyl)amino]hexanoic acid

실험 절차

The title compound was prepared from Nα-isobutyl-Nα-(4-methylbenzenesulfonyl)-L-lysine hydroclloride (200 mg, 0.59 mmol, example 1, step E) as described in general procedure Bc using Nα-(4-nitrobenzenesulfonyl)-L-tryptophan (300 mg, 0.75 mmol) prepared in step A of example 5. The intermediate, Nα-isobutyl-Nα-(4-methylbenzenesulfonyl)-Nε-[N′α-(4-nitrobenzenesulfonyl)-L-tryptophanyl]-L-lysine, was reduced following the conditions of general procedure E. The final product was purified by preparative HPLC to yield 266 mg (58%) of the desired material.

후처리

  1. customThe final product was purified by preparative HPLC

출처 및 근거

ORD 기록
ord-511cb463996845018b2d47456ae760c2
출처 데이터셋
uspto-grants-2003_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06610689B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트